Logo image of ALMEX.PA

MEXEDIA SPA (ALMEX.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALMEX - IT0005450819 - Common Stock

13.3 EUR
-2.2 (-14.19%)
Last: 11/24/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALMEX gets a fundamental rating of 3 out of 10. We evaluated ALMEX against 28 industry peers in the Diversified Telecommunication Services industry. The financial health of ALMEX is average, but there are quite some concerns on its profitability. ALMEX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALMEX had negative earnings in the past year.
ALMEX had a positive operating cash flow in the past year.
ALMEX had positive earnings in 4 of the past 5 years.
In multiple years ALMEX reported negative operating cash flow during the last 5 years.
ALMEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALMEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -12.70%, ALMEX is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
ALMEX's Return On Equity of -42.25% is on the low side compared to the rest of the industry. ALMEX is outperformed by 82.14% of its industry peers.
Industry RankSector Rank
ROA -12.7%
ROE -42.25%
ROIC N/A
ROA(3y)-1.83%
ROA(5y)2.5%
ROE(3y)-9.5%
ROE(5y)5.81%
ROIC(3y)N/A
ROIC(5y)N/A
ALMEX.PA Yearly ROA, ROE, ROICALMEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

ALMEX has a Gross Margin of 10.15%. This is in the lower half of the industry: ALMEX underperforms 78.57% of its industry peers.
In the last couple of years the Gross Margin of ALMEX has grown nicely.
ALMEX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.41%
GM growth 5Y36.9%
ALMEX.PA Yearly Profit, Operating, Gross MarginsALMEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

More info and screens

6

2. Health

2.1 Basic Checks

ALMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALMEX remains at a similar level compared to 1 year ago.
ALMEX has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for ALMEX has been reduced compared to a year ago.
ALMEX.PA Yearly Shares OutstandingALMEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALMEX.PA Yearly Total Debt VS Total AssetsALMEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALMEX has an Altman-Z score of 0.38. This is a bad value and indicates that ALMEX is not financially healthy and even has some risk of bankruptcy.
ALMEX's Altman-Z score of 0.38 is on the low side compared to the rest of the industry. ALMEX is outperformed by 78.57% of its industry peers.
The Debt to FCF ratio of ALMEX is 3.19, which is a good value as it means it would take ALMEX, 3.19 years of fcf income to pay off all of its debts.
ALMEX's Debt to FCF ratio of 3.19 is amongst the best of the industry. ALMEX outperforms 92.86% of its industry peers.
ALMEX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ALMEX has a Debt to Equity ratio of 0.10. This is amongst the best in the industry. ALMEX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.19
Altman-Z 0.38
ROIC/WACCN/A
WACC7.08%
ALMEX.PA Yearly LT Debt VS Equity VS FCFALMEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 1.12 indicates that ALMEX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, ALMEX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
A Quick Ratio of 1.12 indicates that ALMEX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.12, ALMEX belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
ALMEX.PA Yearly Current Assets VS Current LiabilitesALMEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALMEX have decreased strongly by -547.54% in the last year.
Looking at the last year, ALMEX shows a very negative growth in Revenue. The Revenue has decreased by -77.49% in the last year.
Measured over the past years, ALMEX shows a very negative growth in Revenue. The Revenue has been decreasing by -13.26% on average per year.
EPS 1Y (TTM)-547.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.14%
Revenue 1Y (TTM)-77.49%
Revenue growth 3Y-17.91%
Revenue growth 5Y-13.26%
Sales Q2Q%169.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y88.15%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMEX.PA Yearly Revenue VS EstimatesALMEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ALMEX.PA Yearly EPS VS EstimatesALMEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALMEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 5.08, the valuation of ALMEX can be described as very cheap.
ALMEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALMEX is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALMEX to the average of the S&P500 Index (34.45), we can say ALMEX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.08
ALMEX.PA Price Earnings VS Forward Price EarningsALMEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALMEX is valued a bit more expensive than 67.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 48.32
EV/EBITDA N/A
ALMEX.PA Per share dataALMEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ALMEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALMEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEXEDIA SPA

EPA:ALMEX (11/24/2025, 7:00:00 PM)

13.3

-2.2 (-14.19%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap75.81M
Revenue(TTM)138.64M
Net Income(TTM)-20.01M
Analysts86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.08
P/S 1.04
P/FCF 48.32
P/OCF 9.18
P/B 1.6
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.07
EYN/A
EPS(NY)2.62
Fwd EY19.67%
FCF(TTM)0.28
FCFY2.07%
OCF(TTM)1.45
OCFY10.89%
SpS12.79
BVpS8.31
TBVpS-4.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.7%
ROE -42.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.15%
FCFM 2.15%
ROA(3y)-1.83%
ROA(5y)2.5%
ROE(3y)-9.5%
ROE(5y)5.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.41%
GM growth 5Y36.9%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.19
Debt/EBITDA N/A
Cap/Depr 520.54%
Cap/Sales 9.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 0.38
F-Score4
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)961.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-547.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.14%
EPS Next Y88.15%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-77.49%
Revenue growth 3Y-17.91%
Revenue growth 5Y-13.26%
Sales Q2Q%169.9%
Revenue Next Year7.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-293.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y114.78%
FCF growth 3YN/A
FCF growth 5Y-13.29%
OCF growth 1Y16092.2%
OCF growth 3YN/A
OCF growth 5Y20.87%

MEXEDIA SPA / ALMEX.PA FAQ

What is the fundamental rating for ALMEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALMEX.PA.


What is the valuation status for ALMEX stock?

ChartMill assigns a valuation rating of 4 / 10 to MEXEDIA SPA (ALMEX.PA). This can be considered as Fairly Valued.


How profitable is MEXEDIA SPA (ALMEX.PA) stock?

MEXEDIA SPA (ALMEX.PA) has a profitability rating of 2 / 10.


How financially healthy is MEXEDIA SPA?

The financial health rating of MEXEDIA SPA (ALMEX.PA) is 6 / 10.